 |
 |  |  |  |  |  | |  |
| | | Improve your diagnostic confidence in cardiac CTA using Philips IMR | |
Being able to see the plaque producing stenosis is critical in order to make a confident diagnosis in Cardiac CT Angiography (CTA). Standard reconstruction techniques are prone to increased image noise and artifacts, particularly at a low dose.
Dr. Weigold discusses how the ability of Philips IMR to lower noise and improve low contrast resolution helps to overcome challenges associated with plaque identification at low dose levels. |
|
|
|
| |
| | | With IMR benefits are achieved simultaneously. | | | You can achieve 60 - 80% lower dose, and at the same time, improve low-contrast detectability by 43 - 80% and lower image noise by 70 - 83%, relative to standard (FBP) reconstruction.* | |  | | | The coinciding benefits of IMR provide you the ability to see fine subtle differences that may have been missed in the past. These subtleties can be vital to the care you provide your patients. | | | * In clinical practice, the use of IMR may reduce CT patient dose depending on the clinical task, patient size, anatomical location, and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task. Low-contrast detectability and noise were assessed using Reference Factory Protocol comparing IMR to FBP; measured on 0.8 mm slices, tested on the MITA CT IQ Phantom (CCT183, The Phantom Laboratory), using human observers. | |  | | © Koninklijke Philips N.V., 2013. All rights reserved. This email was sent on behalf of Philips Healthcare Headquarters, 3000 Minuteman Road, Andover, Massachusetts 01810, United States.
We respect your right to privacy - view our policy. | |  | |
| |
| | |  |  |  |  |  |
 |
|
Posts
